TractManager, Inc. Acquires Hayes, Inc.
CHATTANOOGA, TN, DALLAS, TX November 15, 2017/Business Wire. TractManager, Inc., the healthcare industry’s largest supplier of strategic sourcing and contract lifecycle management (CLM) solutions, has acquired Hayes, Inc., an industry leader in providing clinically focused, evidence-based research and analysis to health plans, insurers, hospitals, healthcare systems, ACOs, and government agencies.
“We are thrilled to welcome Hayes into our corporate family,” said Trace Devanny, chief executive officer of TractManager. “As a highly respected leader in health technology research and consulting, Hayes uniquely supports providers and payers with the quality, outcomes, and comparative effectiveness data they need to make fact-based decisions. Hayes deepens our professional services sourcing portfolio, and expands the market opportunities for our contract management solutions. Adding a significant dimension to each of our MD Buyline offerings, Hayes data is already integrated with our MedApproved product evaluation workflow solution.”
For more than 25 years, Hayes has been empowering clinicians, health plan policymakers, and government agencies in their mission to make sound, unbiased decisions that balance effectiveness, quality, and patient outcomes. Hayes’ payer clients represent 200 million covered lives in the U.S.
“As the founder and CEO of Hayes, Inc., I wanted to secure our future so we could fulfill our mission and vision, and find a good ‘home’ for Hayes and our exceptional team of research scientists and clinicians that would allow all to thrive and grow. TractManager is that home,” said Winifred S. Hayes, R.N., Ph.D., and A.N.P. “Together, Hayes and the other members of the TractManager family, can truly transform our healthcare system for the benefit of all.”
Donald A. Deieso, Ph.D., Chairman of TractManager’s Board of Directors, and Operating Partner for Arsenal Capital Partners, noted, “Dr. Wini Hayes is a true visionary, who anticipated the need for evidence-based data to support clinical decisions long before the Institute of Medicine published its recent 2020 goal for 90% of clinical decisions to be driven by evidence-based data. She and her wonderful team have an exceptional understanding of the decision-support needs of payers and providers, and we are proud to support their continued innovation and contributions to healthcare.”
Based in Lansdale, Pa., Hayes is dedicated to the delivery of high-quality healthcare and improved outcomes through the integration of evidence into decision-making and policy development. Unbiased information and comparative-effectiveness analyses enable evidence-based decisions about acquiring, managing, and paying for health technologies. Petsky Prunier Securities LLC acted as exclusive financial advisor to Hayes.
TractManager’s healthcare-specific application suite serves three out of five U.S. hospitals. Serving the healthcare industry with integrity for more than 30 years, TractManager is the first-mover in strategic sourcing and enterprise contract lifecycle management. Our advisory services wrap around each solution component, optimizing purchasing and service category management, while supporting best-practice contracting processes. The company’s strategic sourcing division, MD Buyline, includes Hayes, the recently acquired industry leader in providing clinically focused, evidence-based research and analysis to health plans, insurers, hospitals, healthcare systems, ACOs, and government agencies, and MedApproved, a new product approval workflow solution. The MediTract division supports hospitals and healthcare facilities with an enterprise contract lifecycle solution. Together, we are dedicated to helping our clients reduce their capital and non-labor costs, and conform their contract, policy, and procedure management to meet regulatory requirements.
About Arsenal Capital Partners
Formed in 2000, Arsenal Capital Partners is a leading New York-based private equity firm that invests in specialty industrial and healthcare companies. Arsenal targets businesses with the potential for further value creation by working closely with management to accelerate growth and leverage the firm’s operational improvement capabilities. Since inception, Arsenal has raised institutional equity investment funds totaling $3 billion.
Sandra L. Taylor, Ph.D.
Chief Marketing Officer